This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Dividendos de Signify Health

Dividendo controles de criterios 0/6

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria	1.7%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	US$0.43
Rentabilidad por dividendo prevista a 3 años	0%

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

CVS Health to offer bonds to finance purchase of Signify Health

Feb 13

Signify Health and Prospect Medical come together to deliver coordinated, high-quality care

Jan 11

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if SGFY's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if SGFY's dividend payments have been increasing.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Signify Health vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de SGFY con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (SGFY)	n/a
Suelo de mercado 25% (US)	1.6%
Techo de mercado 25% (US)	4.8%
Media de la industria (Healthcare)	1.7%
Previsión de analistas en 3 años (SGFY)	0%

Dividendo destacado: Unable to evaluate SGFY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate SGFY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as SGFY has not reported any payouts.

This company listing is no longer active

Dividendos de Signify Health

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

Consensus EPS estimates fall by 14%

Full year 2022 earnings: Revenues miss analyst expectations

Price target increased by 7.5% to US$29.42

CVS Health to offer bonds to finance purchase of Signify Health

Signify Health and Prospect Medical come together to deliver coordinated, high-quality care

Checking Signify Health Before The CVS Transaction

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Signify Health Expands In-Home Diagnostic and Preventive Services Offering, Introduces Spirometry Test for Detecting COPD

Signify expands diagnostic offering with spirometry test for lung disease

Signify Health, Inc. Receives NCQA’s HEDIS Allowable Adjustments Certification

CVS Pharmacy, Inc. entered into a definitive agreement to acquire Signify Health, Inc. (NYSE:SGFY) from New Mountain Capital, L.L.C. and others for $7.4 billion.

Price target increased to US$28.65

CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Signify Health, Inc. (NYSE:SGFY) from New Mountain Capital, L.L.C. and others for $7.3 billion.

Signify Health jumps on report CVS in talks to acquire for about $8 billion

Price target increased to US$26.60

Amazon Reportedly Among Bidders for Signify Health

Signify Health: Cathie Wood Now Selling

Price target increased to US$24.00

CVS Health Reportedly Plans to Bid for Signify Health

CVS Health seeking purchase of Signify Health - WSJ

Second quarter 2022 earnings: EPS misses analyst expectations

Signify Health: ECS Wind Down Sheds Light On Compelling Valuation

Signify Health, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Signify Health, Inc. Names Paymon Farazi as Chief Product Officer

Investor sentiment improved over the past week

Consensus forecasts updated

President recently bought US$126k worth of stock

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Signify Health, Inc. Provides Earnings Guidance for the Full Year of 2022

High number of new directors

Signify Health, Inc. to Report Q1, 2022 Results on May 04, 2022

Consensus forecasts updated

Signify Health Aims Higher With New CMS Terms

Signify Health, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$24.78

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Signify Health, Inc. (NYSE:SGFY) entered into an agreement to acquire Caravan Health, Inc. for $300 million.

Signify Health, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Revisiting Signify Health

Carecentrix Alleges Suit Against Signify

President recently bought US$302k worth of stock

Third quarter 2021 earnings released: EPS US$0.12 (vs US$69.19 loss in 3Q 2020)

High number of new directors

Forecast breakeven pushed back to 2022

Forecast breakeven pushed back to 2022

Signify Health Provides Financial Guidance for 2021

Signify Health, Inc.(NYSE:SGFY) dropped from Russell 2500 Growth Index

Signify Health names Susan Yun as chief people officer

First quarter 2021 earnings released: US$0.14 loss per share (vs US$85.74 loss in 1Q 2020)

Signify Health, Inc. Maintains Earnings Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released: US$66.23 loss per share (vs US$305 loss in FY 2019)

Signify Health, Inc. Provides Revenue Guidance for the Full Year 2021

Signify Health, Inc. to Report Q4, 2020 Results on Mar 24, 2021

Aspen Physician Network and Signify Health, Inc. Partner to Bring Value-Based Episodes of Care Program to Texas Employers in Dallas-Fort Worth Region

Signify Health, Inc. has completed an IPO in the amount of $564 million.

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Discover strong dividend paying companies